Susquehanna Fundamental Investments, LLC Albireo Pharma, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $218,590 - $353,199	-13,394 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $63,866 - $94,308	-3,014 Reduced 18.37%	13,394 $312,000
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $103,420 - $136,004	-3,780 Reduced 18.72%	16,408 $512,000
Q2 2021 Aug 11, 2021	SELL	$28.9 - $36.87 $153,516 - $195,853	-5,312 Reduced 20.83%	20,188 $710,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $80,042 - $107,082	2,499 Added 10.86%	25,500 $899,000
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $66,307 - $88,578	2,101 Added 10.05%	23,001 $863,000
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $484,671 - $869,649	20,900 New	20,900 $697,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.